Lung Injury as an Immune-Related Adverse Event Following COVID-19 Pneumonia During Combination Therapy with Atezolizumab and Bevacizumab for Hepatocellular Carcinoma
Authors
Kazunobu Aso
Koji Sawada (ORCID: https://orcid.org/0000-0002-9708-4786)
Lung Injury as an Immune-Related Adverse Event Following COVID-19 Pneumonia During Combination Therapy with Atezolizumab and Bevacizumab for Hepatocellular Carcinoma
Kazunobu Aso, Koji Sawada, Shin Otake, Takumu Hasebe et al.
Citations
1 citations
Journal
Kanzo
Topics
COVID-19 Clinical Research Studies
Field-Weighted Citation Impact (FWCI)
1.40
article
Lung Injury as an Immune-Related Adverse Event Following COVID-19 Pneumonia During Combination Therapy with Atezolizumab and Bevacizumab for Hepatocellular Carcinoma